Prognostic factors of patients with pathologic stage I lung adenocarcinoma.
作者信息
Chen Ying-Yi, Huang Tsai-Wang
机构信息
Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei.
出版信息
J Thorac Dis. 2018 Apr;10(Suppl 9):S1115-S1118. doi: 10.21037/jtd.2018.04.37.
Abstract
摘要
相似文献
1
Prognostic factors of patients with pathologic stage I lung adenocarcinoma.病理I期肺腺癌患者的预后因素
J Thorac Dis. 2018 Apr;10(Suppl 9):S1115-S1118. doi: 10.21037/jtd.2018.04.37.
2
Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters.IASLC/ATS/ERS 新分类定义的肿瘤侵袭性对病理分期为 IA 期肺腺癌具有预后意义，并可通过影像学参数预测。
J Thorac Cardiovasc Surg. 2014 Jan;147(1):54-9. doi: 10.1016/j.jtcvs.2013.08.058. Epub 2013 Oct 13.
3
[Prognostic significance and grading of stromal invasion in pT1 adenocarcinoma of lung].[肺pT1期腺癌间质浸润的预后意义及分级]
Zhonghua Bing Li Xue Za Zhi. 2009 Jul;38(7):451-5.
4
Prognostic stratification model for patients with stage I non-small cell lung cancer adenocarcinoma treated with surgical resection without adjuvant therapies using metabolic features measured on F-18 FDG PET and postoperative pathologic factors.采用 F-18 FDG PET 测量的代谢特征和术后病理因素对未接受辅助治疗的 I 期非小细胞肺癌腺癌患者进行手术切除的预后分层模型。
Lung Cancer. 2018 May;119:1-6. doi: 10.1016/j.lungcan.2018.02.013. Epub 2018 Mar 2.
5
The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer.国际肺癌研究协会分期项目：手术治疗的非小细胞肺癌的预后因素及病理TNM分期
J Thorac Oncol. 2009 Jul;4(7):792-801. doi: 10.1097/JTO.0b013e3181a7716e.
6
Ground-Glass Opacity Is a Strong Prognosticator for Pathologic Stage IA Lung Adenocarcinoma.磨玻璃密度影是 I 期肺腺癌病理分期的强有力预测指标。
Ann Thorac Surg. 2019 Jul;108(1):249-255. doi: 10.1016/j.athoracsur.2019.01.079. Epub 2019 Mar 12.
7
Molecular profiling identifies prognostic markers of stage IA lung adenocarcinoma.分子谱分析可识别IA期肺腺癌的预后标志物。
Oncotarget. 2017 Aug 24;8(43):74846-74855. doi: 10.18632/oncotarget.20420. eCollection 2017 Sep 26.
8
The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma.非贴壁生长型的病理浸润成分大小在Ⅰ期肺腺癌中的预后作用。
J Thorac Cardiovasc Surg. 2013 Sep;146(3):580-5. doi: 10.1016/j.jtcvs.2013.04.032. Epub 2013 Jun 15.
9
Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer.肿瘤内血管侵犯对完全切除的病理I期非小细胞肺癌的预后影响
J Thorac Cardiovasc Surg. 2009 Feb;137(2):429-34. doi: 10.1016/j.jtcvs.2008.07.007. Epub 2008 Sep 14.
10
Prognostic impact of large cell neuroendocrine histology in patients with pathologic stage Ia pulmonary non-small cell carcinoma.大细胞神经内分泌组织学对病理分期为Ia期的肺非小细胞癌患者的预后影响。
J Thorac Cardiovasc Surg. 2006 Aug;132(2):312-5. doi: 10.1016/j.jtcvs.2006.02.046.
引用本文的文献
1
Lymph node micrometastasis in N stage: a call for more evidence.N 期淋巴结微转移：需要更多证据
J Thorac Dis. 2018 Jul;10(Suppl 18):S2219-S2220. doi: 10.21037/jtd.2018.06.57.
本文引用的文献
1
Prognostic factors in curatively resected pathological stage I lung adenocarcinoma.根治性切除的病理I期肺腺癌的预后因素
J Thorac Dis. 2017 Dec;9(12):5267-5277. doi: 10.21037/jtd.2017.11.65.
2
Pathological prognostic factors of recurrence in early stage lung adenocarcinoma.早期肺腺癌复发的病理预后因素
ANZ J Surg. 2018 Apr;88(4):327-331. doi: 10.1111/ans.14033. Epub 2017 Jul 12.
3
Relationship of Lymph Node Micrometastasis and Micropapillary Component and Their Joint Influence on Prognosis of Patients With Stage I Lung Adenocarcinoma.淋巴结微转移与微乳头成分的关系及其对Ⅰ期肺腺癌患者预后的联合影响。
Am J Surg Pathol. 2017 Sep;41(9):1212-1220. doi: 10.1097/PAS.0000000000000901.
4
Optimal delivery of follow-up care following pulmonary lobectomy for lung cancer.肺癌肺叶切除术后随访护理的优化实施
Lung Cancer (Auckl). 2016 Mar 30;7:29-34. doi: 10.2147/LCTT.S85112. eCollection 2016.
5
Histologic Subtype in Core Lung Biopsies of Early-Stage Lung Adenocarcinoma is a Prognostic Factor for Treatment Response and Failure Patterns After Stereotactic Body Radiation Therapy.早期肺腺癌经皮肺穿刺活检组织学亚型是立体定向体部放疗后治疗反应和失败模式的预后因素。
Int J Radiat Oncol Biol Phys. 2017 Jan 1;97(1):138-145. doi: 10.1016/j.ijrobp.2016.09.037. Epub 2016 Sep 29.
6
KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.KRAS突变是早期肺腺癌的一个重要预后因素。
Am J Surg Pathol. 2016 Dec;40(12):1579-1590. doi: 10.1097/PAS.0000000000000744.
7
Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma.双基因特征提高了IASLC/ATS/ERS分类对早期肺腺癌患者生存预测的鉴别能力。
Onco Targets Ther. 2016 Jul 25;9:4583-91. doi: 10.2147/OTT.S107272. eCollection 2016.
8
Spread through air spaces is a predictive factor of recurrence and a prognostic factor in stage I lung adenocarcinoma.通过气腔播散是Ⅰ期肺腺癌复发的预测因素和预后因素。
Interact Cardiovasc Thorac Surg. 2016 Oct;23(4):567-72. doi: 10.1093/icvts/ivw211. Epub 2016 Jun 26.
9
Prognostic potential of the MDM2 309T>G polymorphism in stage I lung adenocarcinoma.MDM2基因309T>G多态性在Ⅰ期肺腺癌中的预后潜力
Cancer Med. 2016 Aug;5(8):1791-801. doi: 10.1002/cam4.750. Epub 2016 May 26.
10
Characteristics of young lung cancer: Analysis of Taiwan's nationwide lung cancer registry focusing on epidermal growth factor receptor mutation and smoking status.年轻肺癌的特征：以表皮生长因子受体突变和吸烟状况为重点的台湾全国肺癌登记分析
Oncotarget. 2016 Jul 19;7(29):46628-46635. doi: 10.18632/oncotarget.9338.
Zotero 插件